Vol.

No.

August 07, 2026Aug 07, 2026

DOWNLOAD THE PDF

The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access

Cover Story

Podcast The Directors

The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access

By Claire Marie Porter and Paul Goldberg

New pressures notwithstanding, being a cancer center director is still a dream job, two of the nation’s newest cancer center directors said.

Regulatory News

FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial

By Jacquelyn Cobb and Paul Goldberg

Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup

By Sara Willa Ernst

Clinical Guest Editorial

Marketing hope before surgery: Does the new Keytruda commercial tell patients the whole story?

By Raja Flores

Data-driven: Using AI to solve the complexities of cancer

By Johns Hopkins Kimmel Cancer Center Communications

Podcast

What happened at FDA? Replimune approval raises questions

Cancer Policy

Senate leaders introduce revised, bipartisan stopgap bill that would ban OMB from finalizing rule that would politicize science

Federal judge declines to block Medicaid work requirements

HRSA redrafts 340B rebate pilot program after courts block the original version

Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits

In Brief

Stephenson Global Pancreatic Cancer Research Institute awards $6.7M to accelerate pancreatic cancer research

Society for Immunotherapy of Cancer announces 2026 annual award recipients

Alastair Thompson to lead IU’s breast cancer center

Guangfeng Zhou named assistant professor in the Wistar Institute’s Center for Advanced Therapeutics

American College of Surgeons introduces rural cancer care accreditation category

Roswell Park and Burjeel Medical City launch thoracic cancer care collaboration

NYU Langone, Dana-Farber deploy oncology decision support platform

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Clinical Roundup

Phase III XPORT-EC-042 trial in endometrial cancer does not meet primary endpoint

BRCA-negative patients may still be high-risk for breast cancer, study finds

DELFI liquid biopsy detects liver cancer across diverse international populations, Hopkins-led study finds

Mesothelioma cells rewire genes to resist GNE-7883, study finds

Biobank of tumor models reveals cancers’ weak spots, Nature study finds

Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy

How to boost enrollment of Black and Hispanic patients in pediatric clinical trials

Drugs & Targets

FDA approves Pluvicto for mHSPC

NCI Trials

NCI Trials for August 2026

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues